A collaborative effort between pharmaceutical companies, regulatory agencies and academia to qualify biomarkers for kidney toxicity provides a model for investigating and identifying reliable safety markers for preclinical applications.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
A methodology for exploring biomarker – phenotype associations: application to flow cytometry data and systemic sclerosis clinical manifestations
BMC Bioinformatics Open Access 15 September 2015
-
Identification of tubular injury microRNA biomarkers in urine: comparison of next-generation sequencing and qPCR-based profiling platforms
BMC Genomics Open Access 18 June 2014
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Dieterle, F. et al. Nat Biotechnol. 28, 463–469 (2010).
Yu, Y. et al. Nat. Biotechnol. 28, 470–477 (2010).
Vaidya, V.S. et al. Nat. Biotechnol. 28, 478–485 (2010).
Ozer, J.S. et al. Nat. Biotechnol. 28, 486–494 (2010).
Sistare, F.D. et al. Nat. Biotechnol. 28, 446–454 (2010).
Dieterle, F. et al. Nat. Biotechnol. 28, 455–462 (2010).
http://www.fda.gov/oc/initiatives/criticalpath/projectsummary/consortium.html
Bonventre, J.V. et al. Nat. Biotechnol. 28, 436–440 (2010).
Hanley, J.A. & NcNeil, B.J. Radiology 143, 29–36 (1982).
The Food and Drug Administration Biomarker Qualification Review Team. Review of Qualification Data for Biomarkers of Nephrotoxicity Submitted by the Predictive Safety Testing Consortium (FDA CDER, 21 February 2008).
EMEA. Biomarkers Qualification: Guidance to Applicants (doc. ref. EMEA/CHMP/SAWP/72894/2008-CONSULTATION, 24 April 2008).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Warnock, D., Peck, C. A roadmap for biomarker qualification. Nat Biotechnol 28, 444–445 (2010). https://doi.org/10.1038/nbt0510-444
Issue Date:
DOI: https://doi.org/10.1038/nbt0510-444
This article is cited by
-
Tech on the ROC: export threshold and technology adoption interacted
Small Business Economics (2022)
-
BRCA1 and MDM2 as independent blood-based biomarkers of head and neck cancer
Tumor Biology (2016)
-
A methodology for exploring biomarker – phenotype associations: application to flow cytometry data and systemic sclerosis clinical manifestations
BMC Bioinformatics (2015)
-
Identification of tubular injury microRNA biomarkers in urine: comparison of next-generation sequencing and qPCR-based profiling platforms
BMC Genomics (2014)
-
Emerging horizons of salivary diagnostics for periodontal disease
British Dental Journal (2014)